Clinical Trials Directory

Trials / Unknown

UnknownNCT04447521

Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium

A 20-months Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium to Evaluate National Vaccination Strategy

Status
Unknown
Phase
Study type
Observational
Enrollment
3,600 (estimated)
Sponsor
Sciensano · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The investigators will conduct a prospective observational study of non-invasive S. pneumoniae infections in Belgium and characterize serotype distributions to evaluate national vaccination programs.

Detailed description

The investigators will conduct a surveillance of non-invasive S. pneumoniae infections in Belgium (September 2020-May 2025). Monthly, 12 peripheral hospitals will send the first 15 unduplicated clinical S. pneumoniae samples (coming from patients diagnosed with pneumonia, otitits media or sinusitis) to the investigators. The investigators will determine the serotype and the antibiotic resistance profile of these clinical isolates. Whole genome sequencing will be performed on a subset of these isolates. From May 2021, 13 extra participating centers have been added to the study.

Conditions

Timeline

Start date
2020-09-01
Primary completion
2025-05-01
Completion
2025-12-31
First posted
2020-06-25
Last updated
2022-10-27

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04447521. Inclusion in this directory is not an endorsement.